Effects of low‐dose oxcarbazepine administration on developing cerebellum in newborn rat: A stereological study

E. Odacı, S. Kaplan, B. Sahin, O. Baş, F. Gevrek, D. Aygün, B. Unal, O. Sonmez, S. Çolakoğlu, S. Bilgiç
{"title":"Effects of low‐dose oxcarbazepine administration on developing cerebellum in newborn rat: A stereological study","authors":"E. Odacı, S. Kaplan, B. Sahin, O. Baş, F. Gevrek, D. Aygün, B. Unal, O. Sonmez, S. Çolakoğlu, S. Bilgiç","doi":"10.1002/NRC.10103","DOIUrl":null,"url":null,"abstract":"SUMMARY Oxcarbazepine (OXC) is a widely used novel antiepileptic drug that has been available for routine prescription for 10 years. To examine low dose OXC-induced neurotoxic effects on cerebellar development, we administered 25 mg/kg OXC orally to newborn Wistar rats once a day on postnatal days 2-14. Microscopic processed cerebellar sections of the control and treated groups were examined by volumetric analysis. Volume estimations were obtained using the Cavalieri’s principle using a computerized stereological image analyzer (CAST-GRID). The total volume of the cerebellum, white matter and the various cerebellar layers (except extragranular layer) were significantly increased in the treated animals. These data may provide useful implications for the management of OXC-induced developmental neurotoxicity in children exposed to OXC during the late fetal period. Our finings suggest that women suffering from epilepsy should be given OXC carefully only at the lowest effective doses during pregnancy.","PeriodicalId":19198,"journal":{"name":"Neuroscience Research Communications","volume":"18 1","pages":"28-36"},"PeriodicalIF":0.0000,"publicationDate":"2004-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"24","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroscience Research Communications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/NRC.10103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 24

Abstract

SUMMARY Oxcarbazepine (OXC) is a widely used novel antiepileptic drug that has been available for routine prescription for 10 years. To examine low dose OXC-induced neurotoxic effects on cerebellar development, we administered 25 mg/kg OXC orally to newborn Wistar rats once a day on postnatal days 2-14. Microscopic processed cerebellar sections of the control and treated groups were examined by volumetric analysis. Volume estimations were obtained using the Cavalieri’s principle using a computerized stereological image analyzer (CAST-GRID). The total volume of the cerebellum, white matter and the various cerebellar layers (except extragranular layer) were significantly increased in the treated animals. These data may provide useful implications for the management of OXC-induced developmental neurotoxicity in children exposed to OXC during the late fetal period. Our finings suggest that women suffering from epilepsy should be given OXC carefully only at the lowest effective doses during pregnancy.
低剂量奥卡西平对新生大鼠小脑发育的影响:一项体视学研究
奥卡西平(Oxcarbazepine, OXC)是一种应用广泛的新型抗癫痫药物,作为常规处方已有10年的历史。为了研究低剂量OXC对小脑发育的神经毒性作用,我们在出生后2-14天给新生Wistar大鼠口服25 mg/kg OXC,每天1次。用体积分析法检查对照组和治疗组的显微处理小脑切片。使用计算机立体图像分析仪(CAST-GRID)使用卡瓦列里原理获得体积估计。大鼠小脑、白质和小脑各层(颗粒外层除外)的总体积均显著增加。这些数据可能为在胎儿后期暴露于OXC的儿童中OXC诱导的发育性神经毒性的管理提供有用的启示。我们的研究结果表明,患有癫痫的妇女在怀孕期间应谨慎地给予最低有效剂量的OXC。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信